Japan, Oct. 21 -- SPHINGOTEC GMBH has got intellectual property rights for 'ADRENOMEDULLIN (ADM) FOR DIAGNOSIS AND/OR PREDICTION OF DEMENTIA, AND ANTI-ADRENOMEDULLIN BINDER FOR USE IN TREATMENT OR PREVENTION OF DEMENTIA.' Other related details are as follows:
Application Number: JP,2023-174585
Category (FI): A61K39/395@N,C07K14/575,G01N33/68
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 6, 2023
Publication Date: Jan. 9, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
